Navigation Links
ZYDUS enters female health care segment

Zydus Cadila Healthcare Limited, the Ahmedabad based pharmaceutical company has launched a revolutionary drug, Bonmax (raloxifene hydrochloride) consolidating its presence in the female healthcare segment. Bonmax is used in the prevention and treatment of postmenopausal osteoporosis (PMO). The drug comes as third generation drug which not only safe but can also be used for long term. //

PMO primarily occurs due to the deficiency of the oestrogen hormone during the menopausal period in a woman, which usually sets in between 45 to 55 years. In India, PMO affects at least one out of every three menopausal women. It is aptly termed a ‘silent killer,’ as 30 per cent of bone mass is already lost by the time it is detected. If not prevented osteoporosis leads to fractures, mainly of the hip, spine and wrists, and could disable women for life. This disease is characterised by loss of bone mass, thus making bones very fragile thereby increasing the risk of fractures.

Bonmax is a selective estrogen receptor modulator. It maximises bone mass thereby reducing the risk of breast cancer and decreases total and LDL cholesterol. Currently international trials are on to explore its use as a drug to prevent and treat breast cancer.

Bonmax comes to India with an international experience of around four years. There are more than 10 million users of the drug in the US alone. With life expectancy of women in India on the rise, a safe and efficacious therapy can play a critical role in ensuring a healthier and graceful post-menopausal life. The company is optimistic that within the first year of its launch the drug would capture atleast 10 per cent of the Rs. 50 crore postmenopausal drugs market.
'"/>




Page: 1

Related medicine news :

1. RANBAXY - enters anti-AIDS segment
2. Medicis Pharmaceutical company enters pediatric market
3. Risk of allergy more to children staying in day care centers
4. Walk-In Health Centers Launched By The NHS For Commuters
5. Primary Care centers to provide out patient treatment
6. Free HIV Tests Brings Crowd to the Testing Centers
7. NACO to Introduce 400 Additional AIDS/HIV Screening Centers
8. NACO Inaugurates 37 Additional HIV Treatment Centers
9. Radiotherapy Centers in Scotland Undergo Inspection
10. Are call centers turning a deaf ear to potential acoustic shocks?
11. ‘For-profit Dialysis Centers’ in the Spotlight Over Anti-anemia Drug Overdoe
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 29, 2017 , ... ... pharmacist Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March ... common questions regarding thyroid function. , Dr. Izabella Wentz is a licensed ...
(Date:3/28/2017)... NY (PRWEB) , ... March 28, 2017 , ... ... process management software and services, is proud to announce it has joined the ... professional association representing the interests of chronically ill, disabled, and dying Americans of ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in the ... Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most affordable ... the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with the ...
(Date:3/28/2017)... ... 28, 2017 , ... Usually, the impending arrival of warmer weather means the ... about a double chin, this means more anxiety than elation. The cosmetic dermatology experts ... people, a double chin is undesirable,” Dr. Goldman said, “but it seems doubly so ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TORONTO , March 28, 2017 /PRNewswire/ - StarFish ... medical device development firm, announced today that it has ... -based medical device industrial design and productization organization.  ... throughout North America with easier ... talent spanning the design, engineering, regulatory, and manufacturing process. ...
(Date:3/28/2017)... March 28, 2017  Akcea Therapeutics, a subsidiary of Ionis ... company,s board of directors: ... Gabrieli will serve as chairman of the board of Akcea ... commercial officer of Forest Laboratories. Sandford ... "We are excited to announce this ...
(Date:3/28/2017)... , March 28, 2017 ... to reach USD 8.0 billion by 2025, according to ... increasing incidence of infectious diseases and cancer is expected ... in disease diagnosis over the coming years. In addition, ... of autologous and allogenic stem cell therapy, due to ...
Breaking Medicine Technology: